GeneDx (WGS) PT Lowered to $90 at BTIG, Removed from Top Pick List

May 5, 2026 5:42 AM

BTIG analyst Mark Massaro lowered the price target on GeneDx (NASDAQ: WGS) to $90.00 (from $170.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found